Prevalence of extended-spectrum β-lactamases in South America
- 1 January 2008
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 14, 154-158
- https://doi.org/10.1111/j.1469-0691.2007.01869.x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- SENTRY antimicrobial surveillance program report: latin american and brazilian results for 1997 through 2001The Brazilian Journal of Infectious Diseases, 2004
- Extended-Spectrum β-Lactamases in Enterobacteriaceae in Buenos Aires, Argentina, Public HospitalsAntimicrobial Agents and Chemotherapy, 2003
- Early Dissemination of CTX-M-Derived Enzymes in South AmericaAntimicrobial Agents and Chemotherapy, 2002
- An Outbreak of Extended-Spectrum β-Lactamase-ProducingKlebsiellaSpecies in a Neonatal Intensive Care Unit in BrazilInfection Control & Hospital Epidemiology, 2002
- Variations in the Prevalence of Strains Expressing an Extended‐Spectrum β‐Lactamase Phenotype and Characterization of Isolates from Europe, the Americas, and the Western Pacific RegionClinical Infectious Diseases, 2001
- The MYSTIC (meropenem yearly susceptibility test information collection) programmeInternational Journal of Antimicrobial Agents, 1999
- TRANSFERABLE ENZYMATIC RESISTANCE TO THIRD-GENERATION CEPHALOSPORINS DURING NOSOCOMIAL OUTBREAK OF MULTIRESISTANT KLEBSIELLA PNEUMONIAEThe Lancet, 1987
- Evolution of plasmid-coded resistance to broad-spectrum cephalosporinsAntimicrobial Agents and Chemotherapy, 1985
- Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescensInfection, 1983